Literature DB >> 1551985

Recurrent Staphylococcus aureus bacteremia.

A I Hartstein1, M E Mulligan, V H Morthland, R Y Kwok.   

Abstract

Sequential blood isolates from eight patients with 10 episodes of recurrent Staphylococcus aureus bacteremia were typed by restriction endonuclease analysis of plasmid DNA (REAP DNA fingerprinting) and immunoblotting. There were six early recurrences (within 2 months of stopping antimicrobial therapy) and four late recurrences. All early recurrences isolates were identical to initial isolates. These recurrences were defined as possible relapses. Three of four late recurrence isolates were different from the preceding isolates recovered from four patients. This was considered indicative of new infections. There was complete concordance between REAP DNA fingerprinting and immunoblot typing results. However, four isolates lacked plasmid DNA and could be typed only by immunoblotting. All initial isolates from different patients were different types by immunoblotting and by REAP DNA fingerprinting (except for those lacking plasmid DNA). The bacterial traits detected by these methods appear to be stable in vivo for up to 3 months. Relapsing infections were associated with the presence of intravascular foreign bodies and vancomycin therapy of the preceding episodes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1551985      PMCID: PMC265130          DOI: 10.1128/jcm.30.3.670-674.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Epidemiologic and clinical utility of typing systems for differentiating among strains of methicillin-resistant Staphylococcus aureus.

Authors:  M E Mulligan; R D Arbeit
Journal:  Infect Control Hosp Epidemiol       Date:  1991-01       Impact factor: 3.254

2.  Characterisation of methicillin-resistant Staphylococcus aureus by biotyping, immunoblotting and restriction enzyme fragmentation patterns.

Authors:  J E Coia; F Thomson-Carter; D Baird; D J Platt
Journal:  J Med Microbiol       Date:  1990-02       Impact factor: 2.472

3.  Plasmid profiles and restriction enzyme fragmentation patterns of plasmids of methicillin-sensitive and methicillin-resistant isolates of Staphylococcus aureus from hospital and the community.

Authors:  J E Coia; I Noor-Hussain; D J Platt
Journal:  J Med Microbiol       Date:  1988-12       Impact factor: 2.472

4.  Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users.

Authors:  P M Small; H F Chambers
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

5.  Diversity and stability of restriction enzyme profiles of plasmid DNA from methicillin-resistant Staphylococcus aureus.

Authors:  A J Zuccarelli; I Roy; G P Harding; J J Couperus
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

6.  Broviac catheterization in low birth weight infants: incidence and treatment of associated complications.

Authors:  H F Sadiq; S Devaskar; W J Keenan; T R Weber
Journal:  Crit Care Med       Date:  1987-01       Impact factor: 7.598

7.  Nosocomial clonal dissemination of methicillin-resistant Staphylococcus aureus. Elucidation by plasmid analysis.

Authors:  E Rhinehart; D M Shlaes; T F Keys; J Serkey; B Kirkley; C Kim; C A Currie-McCumber; G Hall
Journal:  Arch Intern Med       Date:  1987-03

8.  A comparison of immunoblot and DNA restriction patterns in characterising methicillin-resistant isolates of Staphylococcus aureus.

Authors:  J P Burnie; R C Matthews; W Lee; D Murdoch
Journal:  J Med Microbiol       Date:  1989-08       Impact factor: 2.472

9.  Restriction enzyme analysis of plasmid DNA and bacteriophage typing of paired Staphylococcus aureus blood culture isolates.

Authors:  A I Hartstein; V H Morthland; S Eng; G L Archer; F D Schoenknecht; A L Rashad
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

10.  Immunoblots, antimicrobial resistance, and bacteriophage typing of oxacillin-resistant Staphylococcus aureus.

Authors:  M E Mulligan; R Y Kwok; D M Citron; J F John; P B Smith
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

View more
  10 in total

1.  Methicillin-Resistant Staphylococcus aureus Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

2.  Complicating infectious foci in patients with Staphylococcus aureus or Streptococcus species bacteraemia.

Authors:  M L H Cuijpers; F J Vos; C P Bleeker-Rovers; P F M Krabbe; P Pickkers; A P J van Dijk; G J A Wanten; P D Sturm; W J G Oyen; B J Kullberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-02       Impact factor: 3.267

3.  The Staphylococcus aureus Map protein is an immunomodulator that interferes with T cell-mediated responses.

Authors:  Lawrence Y Lee; Yuko J Miyamoto; Bradley W McIntyre; Magnus Höök; Kirk W McCrea; Damien McDevitt; Eric L Brown
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

4.  Staphylococcus aureus bacteremia and cardiac implantable electronic devices in a county hospital setting: a population-based retrospective cohort study.

Authors:  Sara Pichtchoulin; Ingrid Selmeryd; Elisabeth Freyhult; Pär Hedberg; Jonas Selmeryd
Journal:  Ups J Med Sci       Date:  2021-03-05       Impact factor: 2.384

5.  Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD.

Authors:  Kevin E Chan; H Shaw Warren; Ravi I Thadhani; David J R Steele; Jeffrey L Hymes; Franklin W Maddux; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2012-08-16       Impact factor: 10.121

6.  Methicillin-resistant Staphylococcus aureus infections of the eye and orbit (an American Ophthalmological Society thesis).

Authors:  Preston Howard Blomquist
Journal:  Trans Am Ophthalmol Soc       Date:  2006

Review 7.  Critical issues in the clinical management of complicated intra-abdominal infections.

Authors:  Stijn Blot; Jan J De Waele
Journal:  Drugs       Date:  2005       Impact factor: 9.546

8.  In vivo stability and discriminatory power of methicillin-resistant Staphylococcus aureus typing by restriction endonuclease analysis of plasmid DNA compared with those of other molecular methods.

Authors:  A I Hartstein; C L Phelps; R Y Kwok; M E Mulligan
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

9.  Infectious Disease Consultation for Staphylococcus aureus Bacteremia Improves Patient Management and Outcomes.

Authors:  Alexa A Pragman; Michael A Kuskowski; James M Abraham; Gregory A Filice
Journal:  Infect Dis Clin Pract (Baltim Md)       Date:  2012-07-01

10.  Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis.

Authors:  M de Górgolas; P Avilés; C Verdejo; M L Fernández Guerrero
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.